Meningococcal vaccine groups A C Y W-135 conjugate (Beijing Minhai Biotechnology)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameMeningococcal vaccine groups A C Y W-135 conjugate (Beijing Minhai Biotechnology)
Drug Alias Name4-valent Meningococcal Conjugate Vaccine
ClassificationVaccines > Application > Prophylactic vaccineVaccines > Biological material > Bacterial vaccineVaccines > Development/production technology > Conjugated vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsMeningitis, Meningococcal
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPending (Phase 3 Clinical)
Highest Status in ChinaPending
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Active IndicationsN/A
Inactive IndicationsMeningitis, Meningococcal

Other Information

ATC CodeN/A
Related LinksN/A